Tag: Ankylosing Spondylitis

Dual IL-17A/F blocker significantly reduces spinal radiographic progression in radiographic axSpA

Presented By
Prof. Xenofon Baraliakos, Ruhr-University Bochum, Germany
Trial
Phase 3, BE MOBILE 2
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:38

AxSpA: Higher comorbidity burden worsens radiographic progression

Presented By
Dr Sizheng Steven Zhao, University of Manchester, UK
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:32

Ankylosing spondylitis: Combining biologics with NSAID does not imply reduced radiographic progression

Presented By
Dr Fabian Proft, Charité University Hospital, Germany
Trial
Phase 4, CONSUL
Conference
ACR 2022
Type
News article

1 December 2022 14:08

SELECT-AXIS: 64-week results of upadacitinib in active ankylosing spondylitis

Presented By
Dr Atul Deodhar, Oregon Health & Science University, OR, USA
Trial
SELECT-AXIS 1
Conference
EULAR 2021
Type
Peer-reviewed article

2 August 2021 23:25

JAK inhibition as a treatment option for ankylosing spondylitis

Presented By
Prof. Atul Deodhar, Oregon Health & Science University, USA
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 11:02

Signs of benefit for T2T in axial spondyloarthritis

Trial
Cohort study, TICOSPA
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 10:53

Artificial intelligence can help in the diagnosis of axSPA

Presented By
Prof. Denis Poddubnyy, Charité Universitätsmedizin Berlin, Germany
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 10:53

TNF-α inhibitors improve bone mineral density in AS patients

Presented By
Mark Siderius, University Medical Center Groningen; Medical Center Leeuwarden, the Netherlands
Conference
EULAR 2020
Type
Peer-reviewed article

14 August 2020 10:13

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By
Dr Evelyne Vinet, McGill University, Montreal, Canada
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 23:12

JAK1 inhibition shows remarkable efficacy in AS

Presented By
Prof. Désirée van der Heijde, Leiden University Medical Center, the Netherlands
Trial
Phase 3, SELECT-AXIS 1
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 20:57

CARDAS study shows increased prevalence of cardiac valvular disorders in AS patients

Presented By
Mr Milad Baniaamam, Amsterdam University Medical Center, the Netherlands
Trial
CARDAS
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 10:04

NSAIDs consumption is linked to patient-assessed disease activity and decreases with use of TNF inhibitors

Presented By
Dr Olafur Palsson, University Hospital Reykjavik, Iceland
Trial
ICEBIO database
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 10:11

IBD risk of treatment with IL-17 antagonists

Presented By
Dr Wolfgang Eigner, Medical University of Vienna, Austria
Conference
ECCO 2019
Type
Peer-reviewed article

9 May 2019 14:37

Synergistic effect NSAIDs plus TNFi in slowing radiographic progression in ankylosing spondylitis patients

Presented By
Dr Gensler, University of California San Francisco Medical Center, USA
Conference
EULAR 2018
Type
Peer-reviewed article

24 August 2018 22:48
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com